328 related articles for article (PubMed ID: 35477313)
1. Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.
Breen P; Zimbric M; Opron K; Caverly LJ
mSphere; 2022 Jun; 7(3):e0010422. PubMed ID: 35477313
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
Adjemian J; Olivier KN; Prevots DR
Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781
[TBL] [Abstract][Full Text] [Related]
3. Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.
Caverly LJ; Carmody LA; Haig SJ; Kotlarz N; Kalikin LM; Raskin L; LiPuma JJ
PLoS One; 2016; 11(4):e0153876. PubMed ID: 27093603
[TBL] [Abstract][Full Text] [Related]
4. Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease.
Hull RC; Huang JTJ; Barton AK; Keir HR; Ellis H; Cookson WOC; Moffatt MF; Loebinger MR; Chalmers JD
Chest; 2022 May; 161(5):1180-1191. PubMed ID: 34838525
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection.
Caverly LJ; Zimbric M; Azar M; Opron K; LiPuma JJ
ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 33898611
[TBL] [Abstract][Full Text] [Related]
6. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Martiniano SL; Nick JA; Daley CL
Clin Chest Med; 2022 Dec; 43(4):697-716. PubMed ID: 36344075
[TBL] [Abstract][Full Text] [Related]
8. Environmental predictors of pulmonary nontuberculous mycobacteria (NTM) sputum positivity among persons with cystic fibrosis in the state of Florida.
Foote SL; Lipner EM; Prevots DR; Ricotta EE
PLoS One; 2021; 16(12):e0259964. PubMed ID: 34882686
[TBL] [Abstract][Full Text] [Related]
9. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.
De P; Amin AG; Graham B; Martiniano SL; Caceres SM; Poch KR; Jones MC; Saavedra MT; Malcolm KC; Nick JA; Chatterjee D
J Cyst Fibros; 2020 Sep; 19(5):801-807. PubMed ID: 32624408
[TBL] [Abstract][Full Text] [Related]
10. Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019).
Marshall JE; Mercaldo RA; Lipner EM; Prevots DR
BMC Infect Dis; 2023 Jul; 23(1):489. PubMed ID: 37488500
[TBL] [Abstract][Full Text] [Related]
11. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
[TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
[TBL] [Abstract][Full Text] [Related]
13. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
Martiniano SL; Nick JA; Daley CL
Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
[TBL] [Abstract][Full Text] [Related]
14. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
Low D; Wilson DA; Flume PA
J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
[TBL] [Abstract][Full Text] [Related]
15. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis.
Moore JE; Millar BC
Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.
Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA
BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.
Binder AM; Adjemian J; Olivier KN; Prevots DR
Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the airway microbiome in nontuberculous mycobacteria disease.
Sulaiman I; Wu BG; Li Y; Scott AS; Malecha P; Scaglione B; Wang J; Basavaraj A; Chung S; Bantis K; Carpenito J; Clemente JC; Shen N; Bessich J; Rafeq S; Michaud G; Donington J; Naidoo C; Theron G; Schattner G; Garofano S; Condos R; Kamelhar D; Addrizzo-Harris D; Segal LN
Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30093571
[TBL] [Abstract][Full Text] [Related]
19. Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway.
Nick JA; Malcolm KC; Hisert KB; Wheeler EA; Rysavy NM; Poch K; Caceres S; Lovell VK; Armantrout E; Saavedra MT; Calhoun K; Chatterjee D; Aboellail I; De P; Martiniano SL; Jia F; Davidson RM
Tuberculosis (Edinb); 2023 Jan; 138():102276. PubMed ID: 36417800
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.
Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD
Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
